Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Br J Clin Pharmacol ; 2(6): 481-6, 1975 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9952

RESUMO

Cimetidine, a new H2-receptor antagonist, was safely administered to eighteen healthy man by the intravenous, intraduodenal or oral route. 2 When gastric secretion was maximally stimulated by either histamine or pentagastrin, the simultaneous administration of cimetidine produced marked inhibition of both acid and pepsin secretion. 3 Cimetidine was well absorbed by mouth and had a blood half-life of 2 hours. 4 Cimetidine was rapidly excreted via the kidneys and about 70% of the excreted material was unchanged drug. 5 Clinical evaluation of cimetidine in patients with peptic ulceration is recommended.


Assuntos
Guanidinas/farmacologia , Antagonistas dos Receptores H2 da Histamina/farmacologia , Imidazóis/farmacologia , Administração Oral , Adulto , Duodeno , Suco Gástrico/metabolismo , Meia-Vida , Histamina/farmacologia , Antagonistas dos Receptores H2 da Histamina/metabolismo , Humanos , Infusões Parenterais , Intubação Gastrointestinal , Masculino , Pessoa de Meia-Idade , Pentagastrina/farmacologia , Pepsina A/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA